(Date:5/9/2008)... -- Ardea Biosciences, Inc.,(Nasdaq: RDEA ), a co...small- molecule therapeutics for the treatment of ...out, today announced that John W. Beck,has been ap...ons and Chief,Financial Officer effective May 27, ...hortly thereafter. The Company also reported recen...
(Date:5/9/2008)...ws Positive Results with X-ray ...ire/ -- Roche today announced one-year,results fro...MRA(TM),(tocilizumab) can significantly inhibit pr...ts with rheumatoid arthritis (RA), a critical meas... also demonstrated that ACTEMRA,reduces disease si...
(Date:5/8/2008)... -- DATATRAK International, Inc.,(Nasdaq: DATA ),...al,eClinical solutions for the clinical trials ind...e first quarter of 2008., For the three months en...y 41% to $2,088,000 and the Company reported a net...h a basic and diluted basis. These,results compare...
(Date:5/8/2008)...r Research Alliance, an,organization comprised of ...03 million Americans to exercise their power over ...his Mother,s Day through Father,s Day., The campa...o key goals:,to activate Americans everywhere to t...er to exercise their collective power over cancer,...
Breaking Medicine Technology:Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 5DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 2World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 4World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 5Clinical depression linked to abnormal emotional brain circuits 46 1Clinical depression linked to abnormal emotional brain circuits 46 2Clinical depression linked to abnormal emotional brain circuits 46 3Drop in breast cancer incidence linked to hormone use not mammograms 44 1Drop in breast cancer incidence linked to hormone use not mammograms 44 2HPV vaccine does not appear to be effective for treating pre existing HPV infection 42 1HPV vaccine does not appear to be effective for treating pre existing HPV infection 42 2HPV vaccine does not appear to be effective for treating pre existing HPV infection 42 3Diabetes appears to increase risk of death for patients with acute coronary syndromes 40 1Diabetes appears to increase risk of death for patients with acute coronary syndromes 40 2...s in Multiple,Sclerosis May Include Direct Activit...est FTY720 stimulates cells,that may help reduce n...ected by multiple sclerosis , · Separately,...ase II clinical study found that the proportion of...ly lower in the,FTY720 groups compared to placebo ...
...07 - Lux Biosciences,Inc., a privately held biote...almic diseases, announced today that the company,s...the subject of two,presentations at the Associatio...annual meeting, being held May 6-10 in Fort,Lauder...ing given on May 5 during a,satellite session of t...
Other Medicine Technology:Data to be presented at AAN Meeting -Study results of drug,candidate for MS 2Data to be presented at AAN Meeting -Study results of drug,candidate for MS 3Data to be presented at AAN Meeting -Study results of drug,candidate for MS 4Data to be presented at AAN Meeting -Study results of drug,candidate for MS 5Data to be presented at AAN Meeting -Study results of drug,candidate for MS 6Data to be presented at AAN Meeting -Study results of drug,candidate for MS 7Data to be presented at AAN Meeting -Study results of drug,candidate for MS 8Data to be presented at AAN Meeting -Study results of drug,candidate for MS 9Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 2Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 3Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 4(Date:5/12/2008)...ay 12 /PRNewswire/ -- Fairbank Farms, a national,g... of selected ground beef,products produced at its ...opper, Shaw,s, BJ,s, and Wilson Farms retail outle...roduct may contain small pieces of hard plastic. A...of 05/13/08, 05/15/08, or a,"Julian date 124" on t...
(Date:5/12/2008)...umer sales increased 25% for the 12 weeks ended Ma...TSDALE, Ariz., May 12 /PRNewswire-FirstCall/ -- Ma...the-counter healthcare company,that develops and m...r ways,to get better(R)," today announced its fina...ar ended March 31, 2008., For the fourth quarter ...
(Date:5/12/2008)...ive prism glasses can significantly improve the vi...ia, a condition that blinds half the visual field ...were invented by Dr. Eli Peli, a Senior Scientist ... in the first community-based multi-center trial o...ue of the Archives of Ophthalmology. The study wa...
(Date:5/12/2008)...nts worldwide verify safety and quality of technic...terial., DENVER, May 12 /PRNewswire/ -- C5 Medica...or the medical device industry, has submitted a 51...Drug Administration (FDA) for,its new technical ce....,ZirDent(TM) is a zirconium material ideally suit...
Breaking Medicine News(10 mins):Health News:Fairbank Farms Issues Voluntary Recall for Selected Ground Beef Products 2Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 2Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 3Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 4Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 5Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 6Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 7Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 8Health News:Prism glasses expand the view for patients with hemianopia 2Health News:Prism glasses expand the view for patients with hemianopia 3Health News:C5 Medical Werks Applies for Clearance, Certification and Licensing for the Global Marketing of ZirDent(TM) Ceramic CAD/CAM Dental Blocks 2...ined that the women who receive abnormal smear tes...necessarily on the brink of cancer, // More inform...t results and ease their fears over cervical cance...abnormal smears found that more than a quarter had...
...Food and Drug Administration has been subjected to...financial improprieties. // Attorney Barbara Van ... criminal investigation of Lester Crawford. She i...trate, in a telephone hearing, on Thursday, that s...
...Health Department of the MCD, nearly 180 employees...e under the axe. // The Health Department of MCD ... apparently used fraudulent methods to secure jobs...nefarious means. It was observed that the sacked e...
...n commenced with a bit of a furore after nearly sc...il immunization, // and this left many sections of...of vaccines started getting depleted by 11 am itse...t of the vaccination drive. Assistant Minister for...
Other Medicine News:Health News:Study Shows That Women Need To Be Explained About The Smear Test 2Pilling-Weck, medium-large clip size, 10mm, rotatable take apart
Insert only, Pilling-Weck medium-large clip size
Insert only, Ethicon, small clip size
Ethicon, small clip size, 10mm, rotatable take apart
Medicine Products: